Detection, molecular function and mechanisms of m5C in cancer

Abstract

	•m5C modifications are dynamically regulated by writers, readers, and erasers, influencing cancer progression, metastasis, and immune evasion.
	•Distinct m5C regulatory networks exist across cancers, modulating oncogenic pathways and therapy responses.
	•m5C signatures serve as biomarkers for cancer prognosis and treatment stratification, highlighting their role in precision oncology.

Keywords

5-methylcytosine / biologic functions / cancer / detection techniques / RNA modification

References

[1] Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187-1200.

[2] Cohn W, Volkin E. Nucleoside-5′-phosphates from ribonucleic acid. Nature. 1951;167(4247):483-484.

[3] Boccaletto P, Stefaniak F, Ray A, et al. MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res 2022;50(D1):D231-D235.

[4] Wiener D, Schwartz S. The epitranscriptome beyond m(6)A. Nat Rev Genet. 2021;22(2):119-131.

[5] Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Science. 2018;361(6409):1346-1349.

[6] Yang Y, Hsu PJ, Chen Y, Yang Y. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28(6):616-624.

[7] Hussain S, Sajini A, Blanco S, et al. NSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs. Cell Rep. 2013;4(2):255-261.

[8] Yang X, Yang Y, Sun B, et al. 5-Methylcytosine promotes mRNA export—NSUN2 as the methyltransferase and ALYREF as an m(5)C reader. Cell Res. 2017;27(5):606-625.

[9] Liu D, Li G, Zuo Y. Function determinants of TET proteins: the arrangements of sequence motifs with specific codes. Brief Bioinform. 2019;20(5):1826-1835.

[10] Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. 1992;89(5):1827-1831.

[11] Fu L, Amato NJ, Wang P, McGowan SJ, Niedernhofer LJ, Wang Y. Simultaneous quantification of methylated cytidine and adenosine in cellular and tissue RNA by nano-flow liquid chromatography-tandem mass spectrometry coupled with the stable isotope-dilution method. Anal Chem. 2015;87(15):7653-7659.

[12] Wang S, Li H, Lian Z, Deng S. The role of RNA modification in HIV-1 infection. Int J Mol Sci. 2022;23(14):7571.

[13] Zhang M, Song J, Yuan W, Zhang W, Sun Z. Roles of RNA methylation on tumor immunity and clinical implications. Front Immunol. 2021;12:641507.

[14] Huang E, Chen L. RNA N6-methyladenosine modification in female reproductive biology and pathophysiology. Cell Commun Signal. 2023;21(1):53.

[15] Xu Y, Zhang M, Zhang Q, et al. Role of main RNA methylation in hepatocellular carcinoma: N6-methyladenosine, 5-methylcytosine, and N1-methyladenosine. Front Cell Dev Biol. 2021;9:767668.

[16] Yu G, Bao J, Zhan M, et al. Comprehensive analysis of m5C methylation regulatory genes and tumor microenvironment in prostate cancer. Front Immunol. 2022;13:914577.

[17] Ponzetti M, Rucci N, Falone S. RNA methylation and cellular response to oxidative stress-promoting anticancer agents. Cell Cycle. 2023;22(8):870-905.

[18] Bohnsack K, Höbartner C, Bohnsack M. Eukaryotic 5-methylcytosine (m5C) RNA methyltransferases: mechanisms, cellular functions, and links to disease. Genes. 2019;10(2):102.

[19] Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20(6):303-322.

[20] Delaunay S, Pascual G, Feng B, et al. Mitochondrial RNA modifications shape metabolic plasticity in metastasis. Nature. 2022;607(7919):593-603.

[21] Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland RC, Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology. 2008;47(3):908-918.

[22] Zhang X, An K, Ge X, et al. NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m(5)C methylation. Breast Cancer Res. 2024;26(1):94.

[23] Chen X, Li A, Sun B, et al. 5-Methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol. 2019;21(8):978-990.

[24] Cui L, Ma R, Cai J, et al. RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target Ther. 2022;7(1):334.

[25] Guo G, Pan K, Fang S, et al. Advances in mRNA 5-methylcytosine modifications: detection, effectors, biological functions, and clinical relevance. Mol Ther Nucleic Acids. 2021;26:575-593.

[26] Buck M, Connick M, Ames B. Complete analysis of tRNA-modified nucleosides by high-performance liquid chromatography: the 29 modified nucleosides of Salmonella typhimurium and Escherichia coli tRNA. Anal Biochem. 1983;129(1):1-13.

[27] Mishima E, Jinno D, Akiyama Y, et al. Immuno-northern blotting: detection of RNA modifications by using antibodies against modified nucleosides. PLoS One. 2015;10(11):e0143756.

[28] Cui X, Liang Z, Shen L, et al. 5-Methylcytosine RNA methylation in Arabidopsis thaliana. Mol Plant. 2017;10(11):1387-1399.

[29] Wreczycka K, Gosdschan A, Yusuf D, Grüning B, Assenov Y, Akalin A. Strategies for analyzing bisulfite sequencing data. J Biotechnol. 2017;261:105-115.

[30] Yuan F, Bi Y, Siejka-Zielinska P, Zhou Y, Zhang X, Song C. Bisulfite-free and base-resolution analysis of 5-methylcytidine and 5-hydroxymethylcytidine in RNA with peroxotungstate. Chem Commun (Camb). 2019;55(16):2328-2331.

[31] Dai Q, Ye C, Irkliyenko I, et al. Ultrafast bisulfite sequencing detection of 5-methylcytosine in DNA and RNA. Nat Biotechnol. 2024;42:1559–1570.

[32] Saplaoura E, Perrera V, Colot V, Kragler F. Methylated RNA immunoprecipitation assay to study m5C modification in arabidopsis. J Vis Exp 2020;(159).

[33] Khoddami V, Cairns B. Identification of direct targets and modified bases of RNA cytosine methyltransferases. Nat Biotechnol. 2013;31(5):458-464.

[34] van Dijk EL, Jaszczyszyn Y, Naquin D, Thermes C. The third revolution in sequencing technology. Trends Genet. 2018;34(9):666-681.

[35] Lv H, Zhang Z, Li S, Tan J, Chen W, Lin H. Evaluation of different computational methods on 5-methylcytosine sites identification. Brief Bioinform. 2020;21(3):982-995.

[36] Qiu W, Jiang S, Xu Z, Xiao X, Chou K. iRNAm5C-PseDNC: identifying RNA 5-methylcytosine sites by incorporating physical-chemical properties into pseudo dinucleotide composition. Oncotarget. 2017;8(25):41178-41188.

[37] Zhang M, Xu Y, Li L, Liu Z, Yang X, Yu D. Accurate RNA 5-methylcytosine site prediction based on heuristic physical-chemical properties reduction and classifier ensemble. Anal Biochem. 2018;550:41-48.

[38] Ehrlich M, Gama-Sosa MA, Carreira LH, Ljungdahl LG, Kuo KC, Gehrke CW. DNA methylation in thermophilic bacteria: n4-methylcytosine, 5-methylcytosine, and N6-methyladenine. Nucleic Acids Res. 1985;13(4):1399-1412.

[39] Thomas B, Akoulitchev A. Mass spectrometry of RNA. Trends Biochem Sci. 2006;31(3):173-181.

[40] Thüring K, Schmid K, Keller P, Helm M. Analysis of RNA modifications by liquid chromatography-tandem mass spectrometry. Methods. 2016;107:48-56.

[41] Thüring K, Schmid K, Keller P, Helm M. LC-MS analysis of methylated RNA. Methods Mol Biol. 2017;1562:3-18.

[42] Zhang N, Shi S, Jia TZ, et al. A general LC-MS-based RNA sequencing method for direct analysis of multiple-base modifications in RNA mixtures. Nucleic Acids Res. 2019;47(20):e125.

[43] Wang Y, Wei J, Feng L, et al. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Mol Cancer. 2023;22(1):81.

[44] Yu L, Wang Z, Fan Q, et al. mRNA 5-methylcytosine in Eimeria tenella oocysts: an abundant post-transcriptional modification associated with broad-ranging biological processes. Int J Biol Macromol 2024;280(pt 2):135817.

[45] Liao H, Gaur A, McConie H, et al. Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs. Nucleic Acids Res. 2022;50(18):10695-10716.

[46] Jenjaroenpun P, Wongsurawat T, Pereira R, et al. Complete genomic and transcriptional landscape analysis using third-generation sequencing: a case study of Saccharomyces cerevisiae CEN.PK113-7D. Nucleic Acids Res. 2018;46(7):e38.

[47] Sun P, Chen Y, Liu B, et al. DeepMRMP: a new predictor for multiple types of RNA modification sites using deep learning. Math Biosci Eng. 2019;16(6):6231-6241.

[48] Li J, Huang Y, Yang X, Zhou Y, Zhou Y. RNAm5Cfinder: a web-server for predicting RNA 5-methylcytosine (m5C) sites based on random forest. Sci Rep. 2018;8(1):17299.

[49] Song J, Zhai J, Bian E, Song Y, Yu J, Ma C. Transcriptome-wide annotation of m(5)C RNA modifications using machine learning. Front Plant Sci. 2018;9:519.

[50] Chen X, Xiong Y, Liu Y, Chen Y, Bi S, Zhu X. m5CPred-SVM: a novel method for predicting m5C sites of RNA. BMC Bioinf. 2020;21(1):489.

[51] Fang T, Zhang Z, Sun R, et al. RNAm5CPred: prediction of RNA 5-methylcytosine sites based on three different kinds of nucleotide composition. Mol Ther Nucleic Acids. 2019;18:739-747.

[52] Liu K, Chen W. iMRM: a platform for simultaneously identifying multiple kinds of RNA modifications. Bioinformatics. 2020;36(11):3336-3342.

[53] Xue C, Zhao Y, Li L. Advances in RNA cytosine-5 methylation: detection, regulatory mechanisms, biological functions and links to cancer. Biomark Res. 2020;8(1):43.

[54] Zhang Q, Liu F, Chen W, et al. The role of RNA m5C modification in cancer metastasis. Int J Biol Sci. 2021;17(13):3369-3380.

[55] Gu X, Ma X, Chen C, et al. Vital roles of m(5)C RNA modification in cancer and immune cell biology. Front Immunol. 2023;14:1207371.

[56] Han X, Wang M, Zhao Y, Yang Y, Yang Y. RNA methylations in human cancers. Semin Cancer Biol. 2021;75:97-115.

[57] Walbott H, Auxilien S, Grosjean H, Golinelli-Pimpaneau B. The carboxyl-terminal extension of yeast tRNA m5C methyltransferase enhances the catalytic efficiency of the amino-terminal domain. J Biol Chem. 2007;282(32):23663-23671.

[58] Govindaraju G, Jabeena C, Sethumadhavan DV, Rajaram N, Rajavelu A. DNA methyltransferase homologue TRDMT1 in Plasmodium falciparum specifically methylates endogenous aspartic acid tRNA. Biochim Biophys Acta—Gene Regulatory Mechanisms. 2017;1860(10):1047-1057.

[59] Schaefer M, Pollex T, Hanna K, et al. RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage. Genes Dev. 2010;24(15):1590-1595.

[60] Goll MG, Kirpekar F, Maggert KA, et al. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science. 2006;311(5759):395-398.

[61] Tuorto F, Liebers R, Musch T, et al. RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis. Nat Struct Mol Biol. 2012;19(9):900-905.

[62] Xue S, Xu H, Sun Z, et al. Depletion of TRDMT1 affects 5-methylcytosine modification of mRNA and inhibits HEK293 cell proliferation and migration. Biochem Biophys Res Commun. 2019;520(1):60-66.

[63] Chellamuthu A, Gray S. The RNA methyltransferase NSUN2 and its potential roles in cancer. Cells. 2020;9(8):1758.

[64] Hussain S, Sajini A, Blanco S, et al. NSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs. Cell Rep. 2013;4(2):255-261.

[65] Liu Y, Santi D. m5C RNA and m5C DNA methyl transferases use different cysteine residues as catalysts. Proc Natl Acad Sci U S A. 2000;97(15):8263-8265.

[66] Van Haute L, Lee S, McCann BJ, et al. NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs. Nucleic Acids Res. 2019;47(16):8720-8733.

[67] Frye M, Watt F. The RNA methyltransferase misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors. Curr Biol. 2006;16(10):971-981.

[68] Sun Z, Xue S, Xu H, et al. Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells. Epigenomics. 2019;11(4):439-453.

[69] Mei L, Shen C, Miao R, et al. RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57Kip2 by an m5C-dependent manner. Cell Death Dis. 2020;11(4):270.

[70] Hu Y, Chen C, Tong X, et al. NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death Dis. 2021;12(9):495.

[71] Su J, Wu G, Ye Y, et al. NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization. Oncogene. 2021;40(39):5814-5828.

[72] Sun Z, Xue S, Zhang M, et al. Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene. 2020;39(45):6906-6919.

[73] Chen L, Ding J, Wang B, et al. RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m5C-dependent manner. Exp Cell Res. 2021;404(2):112664.

[74] Zhu W, Wan F, Xu W, et al. Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression. Clin Transl Med. 2022;12(9):e1028.

[75] Wang L, Zhang J, Su Y, et al. Distinct roles of m5C RNA methyltransferase NSUN2 in major gynecologic cancers. Front Oncol. 2022;12:786266.

[76] Tong X, Xiang Y, Hu Y, et al. NSUN2 promotes tumor progression and regulates immune infiltration in nasopharyngeal carcinoma. Front Oncol. 2022;12:788801.

[77] Luo G, Xu W, Chen X, et al. NSUN2-mediated RNA m5C modification modulates uveal melanoma cell proliferation and migration. Epigenetics. 2022;17(8):922-933.

[78] Khan M, Rafiq M, Noor A, et al. Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal-recessive intellectual disability. Am Hum Genet. 2012;90(5):856-863.

[79] Gkatza NA, Castro C, Harvey RF, et al. Cytosine-5 RNA methylation links protein synthesis to cell metabolism. PLoS Biol. 2019;17(6):e3000297.

[80] Courtney D, Tsai K, Bogerd HP, et al. Epitranscriptomic addition of m5C to HIV-1 transcripts regulates viral gene expression. Cell Host Microbe. 2019;26(2):217-227.e6.

[81] Cheng J, Chen L, Li Y, et al. RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun. 2018;9(1):2286.

[82] Henry BA, Kanarek JP, Kotter A, Helm M, Lee N. 5-methylcytosine modification of an Epstein-Barr virus noncoding RNA decreases its stability. RNA. 2020;26(8):1038-1048.

[83] Li X, Meng Y. Expression and prognostic characteristics of m(5) C regulators in low-grade glioma. J Cell Mol Med. 2021;25(3):1383-1393.

[84] Jin S, Li J, Shen Y, Wu Y, Zhang Z, Ma H. RNA 5-methylcytosine regulator NSUN3 promotes tumor progression through regulating immune infiltration in head and neck squamous cell carcinoma. Oral Dis. 2022;30(2):313-328.

[85] Pan J, Huang Z, Xu Y. m5C RNA methylation regulators predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Front Oncol. 2021;11:657466.

[86] Paramasivam A, Meena AK, Venkatapathi C, Pitceathly RD, Thangaraj K. Novel biallelic NSUN3 variants cause early-onset mitochondrial encephalomyopathy and seizures. J Mol Neurosci. 2020;70(12):1962-1965.

[87] Van Haute L, Dietmann S, Kremer L, et al. Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat Commun. 2016;7:12039.

[88] Nakano S, Suzuki T, Kawarada L, Iwata H, Asano K, Suzuki T. NSUN3 methylase initiates 5-formylcytidine biogenesis in human mitochondrial tRNA(Met). Nat Chem Biol. 2016;12(7):546-551.

[89] Metodiev MD, Spåhr H, Loguercio Polosa P, et al. NSUN4 is a dual function mitochondrial protein required for both methylation of 12S rRNA and coordination of mitoribosomal assembly. PLoS Genet. 2014;10(2):e1004110.

[90] Navarro IC, Tuorto F, Jordan D, et al. Translational adaptation to heat stress is mediated by RNA 5-methylcytosine in Caenorhabditis elegans. Embo J. 2021;40(6):e105496.

[91] Cui M, Qu F, Wang L, et al. m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker. Cancer Biomark. 2022;33(3):389-400.

[92] He Y, Yu X, Li J, Zhang Q, Zheng Q, Guo W. Role of m(5)C-related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma. Am J Transl Res. 2020;12(3):912-922.

[93] Heissenberger C, Liendl L, Nagelreiter F, et al. Loss of the ribosomal RNA methyltransferase NSUN5 impairs global protein synthesis and normal growth. Nucleic Acids Res. 2019;47(22):11807-11825.

[94] Burgess A, David R, Searle I. Conservation of tRNA and rRNA 5-methylcytosine in the kingdom Plantae. BMC Plant Biol. 2015;15:199.

[95] Zhang X, Wu L, Liu H, et al. NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma. Oncol Lett. 2022;24(6):439.

[96] Yin H, Huang Z, Niu S, et al. 5-Methylcytosine (m(5)C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis. Front Immunol. 2022;13:967921.

[97] Wang Y, Jiang T, Xu J, et al. Mutations in RNA methyltransferase gene NSUN5 confer high risk of outflow tract malformation. Front Cell Dev Biol. 2021;9:623394.

[98] Sharma S, Yang J, Watzinger P, Kötter P, Entian K. Yeast Nop2 and Rcm1 methylate C2870 and C2278 of the 25S rRNA, respectively. Nucleic Acids Res. 2013;41(19):9062-9076.

[99] Haag S, Warda AS, Kretschmer J, Günnigmann MA, Höbartner C, Bohnsack MT. NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs. RNA. 2015;21(9):1532-1543.

[100] Long T, Li J, Li H, et al. Sequence-specific and shape-selective RNA recognition by the human RNA 5-methylcytosine methyltransferase NSun6. J Biol Chem. 2016;291(46):24293-24303.

[101] Selmi T, Hussain S, Dietmann S, et al. Sequence-and structure-specific cytosine-5 mRNA methylation by NSUN6. Nucleic Acids Res. 2021;49(2):1006-1022.

[102] Huang Z, Pan J, Wang H, et al. Prognostic significance and tumor immune microenvironment heterogenicity of m5C RNA methylation regulators in triple-negative breast cancer. Front Cell Dev Biol. 2021;9:657547.

[103] Yang R, Liang X, Wang H, et al. The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation. EBioMedicine. 2021;63:103195.

[104] Fang X, Miao C, Zeng T, et al. Role of m(5) C RNA methylation regulators in colorectal cancer prognosis and immune microenvironment. J Clin Lab Anal. 2022;36(4):e24303.

[105] Huang Y, Huang C, Jiang X, et al. Exploration of potential roles of m5C-related regulators in colon adenocarcinoma prognosis. Front Genet. 2022;13:816173.

[106] Wang W, Huang H, Jiang H, et al. A cross-tissue investigation of molecular targets and physiological functions of Nsun6 using knockout mice. Int J Mol Sci 2022:23(12):6584.

[107] Aguilo F, Li S, Balasubramaniyan N, et al. Deposition of 5-methylcytosine on enhancer RNAs enables the coactivator function of PGC-1α. Cell Rep. 2016;14(3):479-492.

[108] Seethy A, Pethusamy K, Chattopadhyay I, et al. TETology: epigenetic mastermind in action. Appl Biochem Biotechnol. 2021;193(6):1701-1726.

[109] Yang H, Wang Y, Xiang Y, et al. FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation. Proc Natl Acad Sci U S A. 2022;119(12):e2116251119.

[110] Shen H, Ontiveros RJ, Owens MC, et al. TET-mediated 5-methylcytosine oxidation in tRNA promotes translation. J Biol Chem. 2021;296:100087.

[111] Arguello AE, Li A, Sun X, Eggert TW, Mairhofer E, Kleiner RE. Reactivity-dependent profiling of RNA 5-methylcytidine dioxygenases. Nat Commun. 2022;13(1):4176.

[112] Fu L, Guerrero CR, Zhong N, et al. Tet-mediated formation of 5-hydroxymethylcytosine in RNA. J Am Chem Soc. 2014;136(33):11582-11585.

[113] Huang Y, Wang G, Liang Z, Yang Y, Cui L, Liu C. Loss of nuclear localization of TET2 in colorectal cancer. Clin Epigenetics. 2016;8:9.

[114] Chen Y, Yang W, Zhao Y, Yang Y. Dynamic transcriptomic m(5) C and its regulatory role in RNA processing. Wiley Interdiscip Rev RNA. 2021;12(4):e1639.

[115] Kawarada L, Suzuki T, Ohira T, Hirata S, Miyauchi K, Suzuki T. ALKBH1 is an RNA dioxygenase responsible for cytoplasmic and mitochondrial tRNA modifications. Nucleic Acids Res. 2017;45(12):7401-7415.

[116] Ougland R, Jonson I, Moen MN, et al. Role of ALKBH1 in the core transcriptional network of embryonic stem cells. Cell Physiol Biochem. 2016;38(1):173-184.

[117] Liu F, Clark W, Luo G, et al. ALKBH1-mediated tRNA demethylation regulates translation. Cell. 2016;167(3):816-828 e16.

[118] Klec C, Knutsen E, Schwarzenbacher D, et al. ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform. Cell Mol Life Sci. 2022;79(7):391.

[119] Fan J, Kuai B, Wu G, et al. Exosome cofactor hMTR4 competes with export adaptor ALYREF to ensure balanced nuclear RNA pools for degradation and export. Embo J. 2017;36(19):2870-2886.

[120] Cusenza VY, Tameni A, Neri A, Frazzi R. The lncRNA epigenetics: the significance of m6A and m5C lncRNA modifications in cancer. Front Oncol. 2023;13:1063636.

[121] Song H, Zhang J, Liu B, et al. Biological roles of RNA m5C modification and its implications in cancer immunotherapy. Biomark Res. 2022;10(1):15.

[122] Lyabin D, Eliseeva I, Ovchinnikov L. YB-1 protein: functions and regulation. Wiley Interdiscip Rev RNA. 2014;5(1):95-110.

[123] Yang Y, Wang L, Han X, et al. RNA 5-methylcytosine facilitates the maternal-to-zygotic transition by preventing maternal mRNA decay. Mol Cell. 2019;75(6):1188-1202.e11.

[124] Mansfield J, Wilhelm J, Hazelrigg T. Ypsilon Schachtel, a Drosophila Y-box protein, acts antagonistically to Orb in the oskar mRNA localization and translation pathway. Development. 2002;129(1):197-209.

[125] Tatomer DC, Rizzardi LF, Curry KP, Witkowski AM, Marzluff WF, Duronio RJ. Drosophila Symplekin localizes dynamically to the histone locus body and tricellular junctions. Nucleus. 2014;5(6):613-625.

[126] Chen L, Huang M. Oncometabolites in cancer: from cancer cells to the tumor microenvironment. Holistic Integrative Oncol. 2024;3(1):26.

[127] Ren H, Tang X, Lee JJ, et al. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. J Clin Oncol. 2004;22(16):3230-3237.

[128] Uyama H, Tomita Y, Nakamura H, et al. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer. Clin Cancer Res 2006;12(20 pt 1):6043-6048.

[129] Guo Y, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19(3):1997-2007.

[130] Li M, Tao Z, Zhao Y, et al. 5-Methylcytosine RNA methyltransferases and their potential roles in cancer. J Transl Med. 2022;20(1):214.

[131] Xue C, Zhao Y, Li G, Li L. Multi-omic analyses of the m(5)C regulator ALYREF reveal its essential roles in hepatocellular carcinoma. Front Oncol. 2021;11:633415.

[132] Zhai C, Tian Y, Tang Z, Shao L. RNA methyltransferase NSUN2 promotes growth of hepatocellular carcinoma cells by regulating fizzy-related-1 in vitro and in vivo. Kaohsiung J Med Sci. 2021;37(11):991-999.

[133] Zhang C, Qu L, Lian S, et al. PRL-3 promotes ubiquitination and degradation of AURKA and colorectal cancer progression via dephosphorylation of FZR1. Cancer Res. 2019;79(5):928-940.

[134] He Y, Zhang Q, Zheng Q, Yu X, Guo W. Distinct 5-methylcytosine profiles of circular RNA in human hepatocellular carcinoma. Am J Transl Res. 2020;12(9):5719-5729.

[135] Gu X, Zhou H, Chu Q, Zheng Q, Wang J, Zhu H. Uncovering the association between m(5)C regulator-mediated methylation modification patterns and tumour microenvironment infiltration characteristics in hepatocellular carcinoma. Front Cell Dev Biol. 2021;9:727935.

[136] Yang X, Yang F, Lan L, Wen N, Li H, Sun X. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma. Front Genet. 2022;13:972043.

[137] Cheng JX, Chen L, Li Y, et al. RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun. 2018;9(1):1163.

[138] Li Y, Xue M, Deng X, et al. TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal. Cell Stem Cell. 2023;30(8):1072-1090.

[139] Zou Z, Dou X, Li Y, et al. RNA m(5)C oxidation by TET2 regulates chromatin state and leukaemogenesis. Nature. 2024;634(8035):986-994.

[140] Zhang Q, Sun X, Sun J, et al. RNA m(5)C regulator-mediated modification patterns and the cross-talk between tumor microenvironment infiltration in gastric cancer. Front Immunol. 2022;13:905057.

[141] Hu Y, Chen C, Tong X, et al. NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death Dis. 2021;12(9):842.

[142] Ren Y, Liu K, Wang M, et al. De-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells. Oncotarget. 2014;5(16):7093-7104.

[143] Zhang E, He X, Yin D, et al. Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57. Cell Death Dis. 2016;7(2):e2109.

[144] Li Y, Xia Y, Jiang T, et al. Long noncoding RNA DIAPH2-AS1 promotes neural invasion of gastric cancer via stabilizing NSUN2 to enhance the m5C modification of NTN1. Cell Death Dis. 2023;14(4):260.

[145] Mei L, Shen C, Miao R, et al. RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57(Kip2) by an m(5)C-dependent manner. Cell Death Dis. 2020;11(4):270.

[146] Wang K, Zhong W, Long Z, et al. 5-Methylcytosine RNA methyltransferases-related long non-coding RNA to develop and validate biochemical recurrence signature in prostate cancer. Front Mol Biosci. 2021;8:775304.

[147] Zhu W, Wan F, Xu W, et al. Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression. Clin Transl Med. 2022;12(9):e1028.

[148] Sun G, Ma S, Zheng Z, et al. Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer. Front Oncol. 2022;12:965571.

[149] Tan X, Cai Z, Chen G, et al. Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies. Discov Oncol. 2023;14(1):62.

[150] Liu J, Xiao S, Chen J, Lou W, Chen X. A comprehensive analysis for expression, diagnosis, and prognosis of m(5)C regulator in breast cancer and its ncRNA-mRNA regulatory mechanism. Front Genet. 2022;13:822721.

[151] Huang Z, Li J, Chen J, Chen D. Construction of prognostic risk model of 5-methylcytosine-related long non-coding RNAs and evaluation of the characteristics of tumor-infiltrating immune cells in breast cancer. Front Genet. 2021;12:748279.

[152] Li C, Wang S, Xing Z, et al. A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis. Nat Cell Biol. 2017;19(2):106-119.

[153] Huang W, Qi C, Lv S, et al. Determination of DNA and RNA methylation in circulating tumor cells by mass spectrometry. Anal Chem. 2016;88(2):1378-1384.

[154] Zhang R, Li Y, Sun F, et al. RNA methyltransferase NSUN2-mediated m5C methylation promotes Cr(VI)-induced malignant transformation and lung cancer by accelerating metabolism reprogramming. Environ Int. 2024;192:109055.

[155] Elhardt W, Shanmugam R, Jurkowski TP, Jeltsch A. Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties. Biochimie. 2015;112:66-72.

[156] Frye M, Watt F. The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors. Curr Biol. 2006;16(10):971-981.

[157] Yang J, Risch E, Zhang M, Huang C, Huang H, Lu L. Association of tRNA methyltransferase NSUN2/IGF-II molecular signature with ovarian cancer survival. Future Oncol. 2017;13(22):1981-1990.

[158] Yi J, Gao R, Chen Y, et al. Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer. Oncotarget. 2017;8(13):20751-20765.

[159] Chen S, Chen K, Ding L, et al. RNA bisulfite sequencing reveals NSUN2-mediated suppression of epithelial differentiation in pancreatic cancer. Oncogene. 2022;41(22):3162-3176.

[160] Yu X, Zhang Q, Gao F, et al. Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma. Sci Rep. 2021;11(1):17529.

[161] Geng Q, Wei Q, Shen Z, et al. Comprehensive analysis of the prognostic value and immune infiltrates of the three-m5C signature in colon carcinoma. Cancer Manag Res. 2021;13:7989-8002.

[162] Zheng H, Zhu M, Li W, Zhou Z, Wan X. m(5) C and m(6) A modification of long noncoding NKILA accelerates cholangiocarcinoma progression via the miR-582-3p-YAP1 axis. Liver Int. 2022;42(5):1144-1157.

[163] Wang J, Li Y, Xu B, et al. ALYREF drives cancer cell proliferation through an ALYREF-MYC positive feedback loop in glioblastoma. Onco Targets Ther. 2021;14:145-155.

[164] Zottel A, Jovčevska I, Šamec N, et al. Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration. Ther Adv Med Oncol. 2020;12:1758835920915302.

[165] Nagy Z, Seneviratne JA, Kanikevich M, et al. An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability. Nat Commun. 2021;12(1):1881.

[166] Niu X, Peng L, Liu W, et al. A cis-eQTL in NSUN2 promotes esophageal squamous-cell carcinoma progression and radiochemotherapy resistance by mRNA-m(5)C methylation. Signal Transduct Target Ther. 2022;7(1):267.

[167] Wang L, Zhang J, Su Y, et al. Distinct roles of m(5)C RNA methyltransferase NSUN2 in major gynecologic cancers. Front Oncol. 2022;12:786266.

[168] Kang Y, Hu W, Ivan C, et al. Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. J Natl Cancer Inst. 2013;105(19):1485-1495.

[169] Chen T, Xu Z, Luo J, et al. NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 2023;35(10):1782-1798 e8.

[170] Sato K, Tahata K, Akimoto K. Five genes associated with survival in patients with lower-grade gliomas were identified by information-theoretical analysis. Anticancer Res. 2020;40(5):2777-2785.

[171] Dai X, Gonzalez G, Li L, et al. YTHDF2 binds to 5-methylcytosine in RNA and modulates the maturation of ribosomal RNA. Anal Chem. 2020;92(1):1346-1354.

[172] Li Q, Li X, Tang H, et al. NSUN2-mediated m5C methylation and METTL3/METTL14-mediated m6A methylation cooperatively enhance p21 translation. J Cell Biochem. 2017;118(9):2587-2598.

[173] Wu J, Zhao Q, Chen S, et al. NSUN4-mediated m5C modification of circERI3 promotes lung cancer development by altering mitochondrial energy metabolism. Cancer Lett. 2024;605:217266.

[174] Wang H, Feng J, Fu Z, et al. Epitranscriptomic m(5)C methylation of SARS-CoV-2 RNA regulates viral replication and the virulence of progeny viruses in the new infection. Sci Adv. 2024;10(32):eadn9519.

[175] Yankova E, Blackaby W, Albertella M, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593(7860):597-601.

[176] Sakita-Suto S, Kanda A, Suzuki F, Sato S, Takata T, Tatsuka M. Aurora-B regulates RNA methyltransferase NSUN2. Mol Biol Cell. 2007;18(3):1107-1117.

[177] Glasner H, Riml C, Micura R, Breuker K. Label-free, direct localization and relative quantitation of the RNA nucleobase methylations m6A, m5C, m3U, and m5U by top-down mass spectrometry. Nucleic Acids Res. 2017;45(13):8014-8025.

[178] Heiss M, Reichle V, Kellner S. Observing the fate of tRNA and its modifications by nucleic acid isotope labeling mass spectrometry: NAIL-MS. RNA Biol. 2017;14(9):1260-1268.

[179] Zhang N, Shi S, Yoo B, Yuan X, Li W, Zhang S. 2D-HELS MS Seq: a general LC-MS-based method for direct and de novo sequencing of RNA mixtures with different nucleotide modifications. J Vis Exp 2020;(161).

[180] Khoddami V, Cairns B. Transcriptome-wide target profiling of RNA cytosine methyltransferases using the mechanism-based enrichment procedure Aza-IP. Nat Protoc. 2014;9(2):337-361.

[181] Lu H, Giordano F, Ning Z. Oxford nanopore MinION sequencing and GenomeAssembly. Genomics Proteomics Bioinform. 2016;14(5):265-279.

[182] Sabooh MF, Iqbal N, Khan M, Khan M, Maqbool H. Identifying 5-methylcytosine sites in RNA sequence using composite encoding feature into Chou’s PseKNC. J Theor Biol. 2018;452:1-9.

[183] Feng P, Ding H, Yang H, Chen W, Lin H, Chou K. iRNA-PseColl: identifying the occurrence sites of different RNA modifications by incorporating collective effects of nucleotides into PseKNC. Mol Ther Nucleic Acids. 2017;7:155-163.

[184] Xue S, Xu H, Sun Z, et al. Depletion of TRDMT1 affects 5-methylcytosine modification of mRNA and inhibits HEK293 cell proliferation and migration. Biochem Biophys Res Commun. 2019;520(1):60-66.

[185] Kong W, Biswas A, Zhou D, et al. Nucleolar protein NOP2/NSUN1 suppresses HIV-1 transcription and promotes viral latency by competing with Tat for TAR binding and methylation. PLoS Pathog. 2020;16(3):e1008430.

[186] Kosi N, Alić I, Kolačević M, et al. Nop2 is expressed during proliferation of neural stem cells and in adult mouse and human brain. Brain Res. 2015;1597:65-76.

[187] Blaze J, Navickas A, Phillips HL, et al. Neuronal Nsun2 deficiency produces tRNA epitranscriptomic alterations and proteomic shifts impacting synaptic signaling and behavior. Nat Commun. 2021;12(1):4913.

[188] Yan J, Liu J, Huang Z, Huang W, Lv J. FOXC2-AS1 stabilizes FOXC2 mRNA via association with NSUN2 in gastric cancer cells. Hum Cell. 2021;34(6):1755-1764.

[189] Song D, An K, Zhai W, et al. NSUN2-mediated mRNA m(5)C modification regulates the progression of hepatocellular carcinoma. Genomics Proteomics Bioinform. 2023;21(4):823-833.

[190] Chen L, Ding J, Wang B, et al. RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m(5)C-dependent manner. Exp Cell Res. 2021;404(2):112664.

[191] Tong X, Xiang Y, Hu Y, et al. NSUN2 promotes tumor progression and regulates immune infiltration in nasopharyngeal carcinoma. Front Oncol. 2022;12:788801.

[192] Wang N, Tang H, Wang X, Wang W, Feng J. Homocysteine upregulates interleukin-17A expression via NSun2-mediated RNA methylation in T lymphocytes. Biochem Biophys Res Commun. 2017;493(1):94-99.

[193] Yang L, Ren Z, Yan S, et al. Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation. Commun Biol. 2022;5(1):495.

[194] Liu J, Huang T, Chen W, et al. Developmental mRNA m(5)C landscape and regulatory innovations of massive m(5)C modification of maternal mRNAs in animals. Nat Commun. 2022;13(1):2484.

[195] Li H, Jiang H, Huang Z, Chen Z, Chen N. Prognostic value of an m(5)C RNA methylation regulator-related signature for clear cell renal cell carcinoma. Cancer Manag Res. 2021;13:6673-6687.

[196] Xu J, Liu X, Chen Y, Wang Y, Liu T, Yi P. RNA 5-methylcytosine regulators contribute to metabolism heterogeneity and predict prognosis in ovarian cancer. Front Cell Dev Biol. 2022;10:807786.

[197] Xu Z, Chen S, Zhang Y, Liu R, Chen M. Roles of m5C RNA modification patterns in biochemical recurrence and tumor microenvironment characterization of prostate adenocarcinoma. Front Immunol. 2022;13:869759.

[198] Li X, Yang X. Correlation between the RNA methylation genes and immune infiltration and prognosis of patients with hepatocellular carcinoma: a pan-cancer analysis. J Inflamm Res. 2022;15:3941-3956.

[199] Liu T, Hu X, Lin C, et al. 5-Methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma. Ann Transl Med. 2022;10(5):259.

[200] Xue M, Shi Q, Zheng L, et al. Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma. Am J Transl Res. 2020;12(10):6841-6852.

[201] Wang J, Zhu W, Han J, et al. The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer. Cancer Commun. 2021;41(7):560-575.

[202] Liu Y, Zhao Y, Wu R, et al. mRNA m5C controls adipogenesis by promoting CDKN1A mRNA export and translation. RNA Biol 2021;18(sup2):711-721.

[203] Liu Y, Yang Y, Wu R, et al. mRNA m(5)C inhibits adipogenesis and promotes myogenesis by respectively facilitating YBX2 and SMO mRNA export in ALYREF-m(5)C manner. Cell Mol Life Sci. 2022;79(9):481.

[204] Eckwahl M, Xu R, Michalkiewicz J, et al. 5-Methylcytosine RNA modifications promote retrovirus replication in an ALYREF reader protein-dependent manner. J Virol. 2020;94(13):e00544-20.

[205] He Y, Zhang H, Yin F, et al. Novel insights into the role of 5-Methylcytosine RNA methylation in human abdominal aortic aneurysm. Front Biosci (Landmark Ed). 2021;26(11):1147-1165.

[206] Fotovati A, Abu-Ali S, Wang P, et al. YB-1 bridges neural stem cells and brain tumor-initiating cells via its roles in differentiation and cell growth. Cancer Res. 2011;71(16):5569-5578.

[207] Chen S, Cao X, Ben S, et al. Genetic variants in RNA m(5) C modification genes associated with survival and chemotherapy efficacy of colorectal cancer. Cancer Med. 2023;12(2):1376-1388.

[208] Yang L, Yin H, Chen Y, et al. Low expression of PEBP1P2 promotes metastasis of clear cell renal cell carcinoma by post-transcriptional regulation of PEBP1 and KLF13 mRNA. Exp Hematol Oncol. 2022;11(1):87.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.